Operating segments are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision-maker (“CODM”) in deciding how to allocate resources and assess performance. The Company derives substantially all of its revenue from the sale of subscription fees for access to its platform and stand-ready support—a product designed to provide accurate and comprehensive information on healthcare providers and their activities helping its customers optimize everything from product development to go-to-market planning and sales and marketing execution. To assess performance, the Company’s CODM, the Chief Executive Officer, reviews financial information on a consolidated basis. Therefore, the Company determined it has one operating segment and one reportable segment. The accounting policies of the Company’s operating segment are the same as those described in Note 2. Summary of Significant Accounting Policies in the notes to the consolidated financial statements in the 2025 Form 10-K. The CODM uses consolidated net loss to set budgets, evaluate margins, review actual results, and to make decisions whether to reinvest profits into the business, pursue acquisitions and partnerships, repurchase shares, and/or engage in other capital management transactions.

The following table presents the operating financial results of our single reportable segment, including revenue, significant expenses regularly provided to the CODM, and net loss:


	Three Months Ended June 30,						Six Months Ended June 30,
(in thousands)	2026			2025			2026			2025
Revenue	$	55,195		$	60,750		$	111,124		$	119,941
Total cost of revenue		14,654			14,137			28,933			29,568
Sales and marketing		19,158			20,469			38,736			41,122
Product development		6,756			7,968			13,255			17,269
General and administrative		10,806			12,673			22,890			24,942
Other segment items, net (1)(2)		11,618			14,312			210,896			181,828
Benefit from (provision for) income taxes		345			(456	)		3,780			10,430
Net loss	$	(7,452	)	$	(9,265	)	$	(199,806	)	$	(164,358	)

(1)

For the three months ended June 30, 2026, other segment items, net includes a TRA remeasurement gain of $0.1 million, depreciation and amortization expense of $8.5 million, interest expense of $2.6 million, interest income of $1.3 million, transaction, integration, and restructuring expenses of $2.0 million, and a net foreign currency transaction gain of $0.3 million. For the three months ended June 30, 2025, other segment items, net includes a tax receivable agreement remeasurement loss of $2.9 million, depreciation and amortization expense of $9.0 million, interest expense of $3.0 million, interest income of $1.7 million, transaction, integration, and restructuring expenses of $0.7 million, and net foreign currency transaction losses of $0.5 million.

(2)

For the six months ended June 30, 2026, other segment items, net includes a goodwill impairment charge of $197.2 million, a TRA remeasurement gain of $6.6 million, depreciation and amortization expense of $16.9 million, interest expense of $5.3 million, interest income of $2.6 million, transaction, integration, and restructuring expenses of $1.3 million, and a net foreign currency transaction gain of $0.6 million. For the six months ended June 30, 2025, other segment items, net includes a goodwill impairment charge of $176.5 million, a tax receivable agreement remeasurement gain of $17.8 million, depreciation and amortization expense of $17.5 million, interest expense of $5.4 million, interest income of $3.8 million, transaction integration, and restructuring expenses of $1.9 million, net foreign currency transaction losses of $1.5 million, and a loss on the partial extinguishment of debt of $0.5 million.